Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. Total Liabilities 2018–2025
Esperion Therapeutics Inc. annual total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Esperion Therapeutics Inc. total liabilities as of December 31, 2025: 767.9M, a 4.82% increase year-over-year.
- Esperion Therapeutics Inc. total liabilities for 2025 were 767.9M, a 4.82% increase from 2024.
- Esperion Therapeutics Inc. total liabilities for 2024 were 732.5M, a 10.86% increase from 2023.
- Esperion Therapeutics Inc. total liabilities for 2023 were 660.8M, a 15.58% increase from 2022.
- Esperion Therapeutics Inc. total liabilities for 2022 were 571.7M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Esperion Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $768 |
| 2024 | $733 |
| 2023 | $661 |
| 2022 | $572 |
| 2021 | $579 |
| 2020 | $449 |
| 2019 | $194 |
| 2018 | $64 |
Esperion Therapeutics Inc. Total Liabilities — FAQ
Esperion Therapeutics Inc. (ESPR) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESPR's total liabilities history?
The chart and table above show Esperion Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.